Replies to post #41653 on Ayala Pharmaceuticals Inc (ADXS)

[mpreorder]

I can't recall if this has been published already. We knew they were working on some biomarkers. The title indicates they may have found a way to identify patients who will respond better to treatment with Axal. This is significant because the percentage of success will only go up, although in a smaller population.